Supreme Court Will Hear Case on Access to Mifepristone Abortion Pill

Contributing sentiments towards policy:

59% : Health care professionals can provide the drug in-person to patients or prescribe it virtually and mail the medication, according to 2021 and 2023 guidelines from the FDA.
51% : In states where the procedure remains legal, clinics seeing an increase in out-of-state patients have relied on medication abortion -- which is often quicker, easier and cheaper to provide, and which can be prescribed to patients over telemedicine in some states -- as a way to quickly scale up operations.
49% : This case, brought by a group of anti-abortion medical practitioners, concerns the FDA's approval of mifepristone, which was granted more than 20 years ago.
42% : "This administration will continue to stand by FDA's independent approval and regulation of mifepristone as safe and effective," Press Secretary Karine Jean Pierre said.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.